Front Barnett Associates LLC Abbott Laboratories Transaction History

Front Barnett Associates LLC

$833 Million
Q3 2023

A detailed history of Front Barnett Associates LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Front Barnett Associates LLC holds 7,425 shares of ABT stock, worth $853,800. This represents 0.09% of its overall portfolio holdings.

Number of Shares

7,425

Previous 7,936 6.44%

Holding current value

$853,800

Previous $865,000 16.88%

% of portfolio

0.09%

Previous 0.1%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $48,815 - $58,570	-511 Reduced 6.44%	7,425 $719,000
Q2 2023 Aug 11, 2023	SELL	$100.78 - $112.29 $61,979 - $69,058	-615 Reduced 7.19%	7,936 $865,000
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $202,921 - $238,850	-2,095 Reduced 19.68%	8,551 $866,000
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $20,913 - $24,534	-220 Reduced 2.02%	10,646 $1.17 Million
Q3 2022 Nov 07, 2022	SELL	$96.76 - $112.03 $897,739 - $1.04 Million	-9,278 Reduced 46.06%	10,866 $1.05 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $965,888 - $1.17 Million	9,463 Added 88.6%	20,144 $2.19 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $570 - $695	-5 Reduced 0.05%	10,681 $1.26 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $22,297 - $27,301	-193 Reduced 1.77%	10,686 $1.5 Million
Q3 2021 Nov 04, 2021	SELL	$116.66 - $129.06 $54,363 - $60,141	-466 Reduced 4.11%	10,879 $1.29 Million
Q4 2020 Mar 19, 2021	SELL	$105.0 - $114.42 $7,875 - $8,581	-75 Reduced 0.66%	11,345 $1.24 Million
Q2 2020 Aug 04, 2020	SELL	$76.57 - $98.0 $153 - $196	-2 Reduced 0.02%	11,420 $1.04 Million
Q1 2020 May 14, 2020	BUY	$62.82 - $91.86 $76,137 - $111,334	1,212 Added 11.87%	11,422 $901,000
Q4 2019 Feb 12, 2020	SELL	$78.51 - $87.4 $2,119 - $2,359	-27 Reduced 0.26%	10,210 $887,000
Q3 2019 Nov 04, 2019	SELL	$81.84 - $88.74 $31,917 - $34,608	-390 Reduced 3.67%	10,237 $857,000
Q2 2019 Aug 06, 2019	SELL	$72.88 - $85.0 $377,008 - $439,705	-5,173 Reduced 32.74%	10,627 $894,000
Q1 2019 May 07, 2019	BUY	$66.22 - $80.06 $12,449 - $15,051	188 Added 1.2%	15,800 $1.26 Million
Q4 2018 Feb 07, 2019	SELL	$65.56 - $74.27 $23,273 - $26,365	-355 Reduced 2.22%	15,612 $1.13 Million
Q3 2018 Nov 06, 2018	SELL	$60.81 - $73.36 $3,040 - $3,668	-50 Reduced 0.31%	15,967 $1.17 Million
Q2 2018 Aug 08, 2018	SELL	$57.57 - $63.54 $36,556 - $40,347	-635 Reduced 3.81%	16,017 $977,000
Q1 2018 May 07, 2018	SELL	$56.27 - $63.62 $5,570 - $6,298	-99 Reduced 0.59%	16,652 $998,000
Q4 2017 Feb 07, 2018	SELL	$53.68 - $57.47 $17,446 - $18,677	-325 Reduced 1.9%	16,751 $956,000
Q3 2017 Nov 07, 2017	BUY	$48.06 - $53.64 $820,672 - $915,956	17,076	17,076 $911,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Front Barnett Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Front Barnett Associates LLC with notifications on news.

Account

Front Barnett Associates LLC Abbott Laboratories Transaction History